Literature DB >> 8389553

Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis.

M Tateishi1, I Saito, K Yamamoto, N Miyasaka.   

Abstract

OBJECTIVE: To investigate the involvement of Epstein-Barr virus (EBV) in the pathogenesis of Sjögren's syndrome (SS) and to examine whether the spontaneous production of EBV is unique to SS B cell lines.
METHODS: B cell lines were established from peripheral blood mononuclear cells (PBMC) of patients with systemic lupus erythematosus, rheumatoid arthritis, and SS. The cord blood immortalization assay, flow cytometric analysis, and polymerase chain reaction (PCR) were used to detect EBV production by B cell lines.
RESULTS: SS B cell lines produced EBV at a higher frequency, and in significantly larger amounts, than did other B cell lines. However, no correlation with the amount of EBV DNA in the genome of B cell lines was found. PCR analysis revealed that EBV with a B95-8--like U2 region was dominant in SS B cell lines.
CONCLUSION: Spontaneous, massive production of EBV by B cell lines is unique to SS, and may contribute to the polyclonal B cell activation seen in this disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389553     DOI: 10.1002/art.1780360614

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

1.  Possible involvement of IL-12 expression by Epstein-Barr virus in Sjögren syndrome.

Authors:  M Horiuchi; S Yamano; H Inoue; J Ishii; Y Nagata; H Adachi; M Ono; J N Renard; F Mizuno; Y Hayashi; I Saito
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

2.  Immunohistological analysis of tumour growth factor beta 1 expression in normal and inflamed salivary glands.

Authors:  Y Kizu; H Sakurai; S Katagiri; N Shinozaki; M Ono; K Tsubota; J Saito
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

Review 3.  The Epstein-Barr virus in autoimmunity.

Authors:  J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1995

Review 4.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

5.  Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.

Authors:  Yoshifumi Nagata; Hiroko Inoue; Koichi Yamada; Hiroyuki Higashiyama; Kenji Mishima; Yasuhiro Kizu; Ienaka Takeda; Fumio Mizuno; Yoshio Hayashi; Ichiro Saito
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

Review 6.  Ro/SS-A and La/SS-B: autoantigens in Sjögren's syndrome?

Authors:  R J Smeenk
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

7.  Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.

Authors:  Armen Sanosyan; Claire Daien; Anaïz Nutz; Karine Bollore; Anne-Sophie Bedin; Jacques Morel; Valérie Zimmermann; Gaetane Nocturne; Marianne Peries; Nicolas Guigue; Jacques-Eric Gottenberg; Philippe Van de Perre; Xavier Mariette; Edouard Tuaillon
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

Review 8.  New Viral Facets in Oral Diseases: The EBV Paradox.

Authors:  Lilit Tonoyan; Séverine Vincent-Bugnas; Charles-Vivien Olivieri; Alain Doglio
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

Review 9.  Role of Viral Infections in the Pathogenesis of Sjögren's Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1.

Authors:  Hideki Nakamura; Toshimasa Shimizu; Atsushi Kawakami
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

10.  Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome.

Authors:  Jingxiu Xuan; Zhiqian Ji; Bin Wang; Xiaoli Zeng; Rongjuan Chen; Yan He; Peishi Rao; Puqi Wu; Guixiu Shi
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.